How the Uptick in Opioid Litigation is Affecting the Industry: Key Takeaways from the MDLs

May 29, 2019 2:00pm

Jason Parish
Shareholder
Buchanan Ingersoll & Rooney PC (Washington, D.C.)

Edward Rickert
Partner
Quarles & Brady LLP (Chicago, IL)

In the year that has passed since our inaugural event, the Judicial Panel on Multidistrict Litigation has centralized more than 1100 opioid-related lawsuits in the Northern District of Ohio- National Prescription Opiate Litigation, MDL #2804. The DOJ has joined the case as a “friend of the court” to assist with settlement negotiations. Presently, the MDL trial is set for September 2019, with ongoing potential settlement discussions. In this session, our panelists will take a deep dive into the MDL as well as similar proceedings such as the Native American Tribe suits and the Texas counties MDL. Our speakers will provide a thorough analysis of how the outcomes of these cases will affect your business and manufacturing practices. Topics of discussion include:
  • Dissecting the strength of proposed arguments and defenses
  • Understanding the unique challenges of each of these proceedings
  • Evaluating strategies and potential outcomes